We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
Reduced
Closed
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
GC
51
Guggenheim Capital
Illinois
$5.1M +$4.04M +189,890 New
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$5.07M +$4.01M +188,794 New
NFA
53
Nationwide Fund Advisors
Ohio
$4.58M +$3.62M +170,396 New
MAA
54
Managed Account Advisors
New Jersey
$4.55M +$3.6M +169,279 New
Capital Fund Management (CFM)
55
Capital Fund Management (CFM)
France
$4.31M +$3.41M +160,534 New
TA
56
Teachers Advisors
New York
$4.01M +$3.17M +149,109 New
Morgan Stanley
57
Morgan Stanley
New York
$3.94M +$3.12M +146,719 New
EMFAT
58
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.73M +$2.95M +138,638 New
Axa
59
Axa
France
$3.5M +$2.77M +130,398 New
RJA
60
Raymond James & Associates
Florida
$3.21M +$2.54M +119,610 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$3.19M +$2.53M +118,768 New
JP Morgan Chase
62
JP Morgan Chase
New York
$2.96M +$2.34M +110,003 New
Bank of America
63
Bank of America
North Carolina
$2.85M +$2.26M +106,081 New
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$2.81M +$2.23M +104,726 New
BBA
65
BLB&B Advisors
Pennsylvania
$2.77M +$2.19M +102,890 New
Swiss National Bank
66
Swiss National Bank
Switzerland
$2.75M +$2.18M +102,300 New
ProShare Advisors
67
ProShare Advisors
Maryland
$2.6M +$2.06M +96,902 New
N
68
Nuveen
North Carolina
$2.54M +$2.01M +94,388 New
American Century Companies
69
American Century Companies
Missouri
$2.52M +$2M +93,980 New
GBA
70
Garrison Bradford & Associates
New York
$2.5M +$1.98M +93,000 New
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$2.46M +$1.95M +91,483 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.31M +$1.83M +85,967 New
AIG
73
American International Group
New York
$2.11M +$1.67M +78,597 New
Jane Street
74
Jane Street
New York
$2.09M +$1.66M +77,884 New
MNBTD
75
Moody National Bank Trust Division
Texas
$2.08M +$1.65M +77,361 New

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.